Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Study Phase : Discovery
Sponsor : Undisclosed
Deal Size : Undisclosed
Deal Type : Agreement
NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company
Details : Under the terms of the agreement, NeuBase and the Healthcare Company will collaborate on the evaluation of drug candidates for three undisclosed indications.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 21, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Genetic Disease
Highest Development Status : Discovery
Sponsor : Undisclosed
Deal Size : Undisclosed
Deal Type : Agreement